Obesity affects approximately 100 million Indian adults and is linked to over 200 health complications, including heart ...

Last month, the U.S. Food and Drug Administration (the “FDA”) announced in a Declaratory Order the resolution of the shortage of semaglutide ...

Early adopters of GLP-1 drugs have now lost the weight and are beginning to transition off them. How can F&B support the ...

UK pharma leaders warn excessive NHS levies threaten industry growth, urging the government to reform payments. The ABPI ...

New weight loss drugs like Ozempic and Wegovy help suppress appetite, leading to significant weight loss, but they come with ...

Medical device companies presented new data this week at the Advanced Technologies & Treatments for Diabetes conference.

KwaZulu-Natal Health Department reports significant stabilisation in medicine availability, while grappling with critical ...

Spring has nearly sprung and round two of the Inflation Reduction Act (IRA)’s negotiation period has begun. | All of the ...

With official shortages ended, but the first generics gearing up for launch, companies are looking for the next generation of ...

Dwindling supplies of Ozempic are fuelling an “exploding” black market for the drug across Australia, as the medical industry is forced to assess which patients need the popular medication the most.

A rise in the use of non-FDA-approved diabetes and obesity medications has spurred health care professionals and medical ...

Chilean AI-led food tech startup NotCo has unveiled a botanical GLP Booster powder that uses food as a natural Ozempic ...